Pharmaceutical Commerce

JUNE 9, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Drug Pricing

PharmExec

AUGUST 1, 2025

The label update refines language and streamlines the safety section by removing certain adverse events, aligning with placebo group occurrence rates. Previously used with statins, Leqvio's expanded indication now includes monotherapy alongside diet and exercise, broadening its utility.

Labelling

PharmaVoice

JUNE 16, 2025

The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. The 340B Drug Pricing Program has long been a contentious issue for pharma. Please let us know if you have feedback. By Kelly Bilodeau A day in the life of GSK’s U.S.

Hospitals

Pharmaceutical Technology

JULY 18, 2025

Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceutical company ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation. How will RFK Jr’s American dream for vaccines play out?

Packaging

Pharmaceutical Commerce

JUNE 16, 2025

24 Hours in the Hub Still Matters More June 16, 2025 By Chris Dowd, ConnectiveRx Commentary Article Pharmaceutical Commerce Pharmaceutical Commerce - June 2025 Volume 20 Issue 3 Doubling down on patient access and support fundamentals will win out over Washington’s next move.

Insurance Coverage and Processing

BioPharma Dive

JUNE 9, 2025

By Ned Pagliarulo • June 4, 2025 George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. You can unsubscribe at anytime. By Jonathan Gardner • Sept. By Jonathan Gardner • Sept. © 2025 TechTarget, Inc.

Drug Pricing

PharmExec

AUGUST 7, 2025

months, and serious adverse events in 33% of patients. Serious adverse events (SAEs) were reported in 33% of patients. Allen, PhD, chief scientific officer, Chimerix, a Jazz Pharmaceuticals Company, in the press release. Phase II trials showed a 22% objective response rate, with a median response duration of 10.3

Communication

Pharmaceutical Technology

JULY 16, 2025

The initiative comes at a crucial time, as British pharmaceutical companies are significantly increasing their investments in the United States. GSK invested $800m in drug substance and drug product manufacturing facilities in the US in October 2024. How will RFK Jr’s American dream for vaccines play out?

Packaging

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmaceutical Technology

JUNE 18, 2025

More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceutical companies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US.

Drug Pricing

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. How will RFK Jr’s American dream for vaccines play out? Credit: Zentiva Group, a.s. The partnership will enhance the availability of the affordable biosimilar on a global scale.

Biosimilars

BioPharma Dive

JULY 16, 2025

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. You can unsubscribe at anytime. By Jonathan Gardner • Sept. Will RFK Jr. lend a hand? as Scientific Advisor From Receptor.AI

Drug Pricing

Pharmaceutical Commerce

JULY 10, 2025

Jacqueline Durett Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market. All buzz-building activities must align with applicable government regulations and internal company policies.

Communication

Pharmacy Times

AUGUST 5, 2025

Pharmaceutical companies benefit from extended R&D tax incentives and reshoring manufacturing, favoring long-term investment. Critics argue the bill prioritizes pharmaceutical profits, reduces Medicare's negotiation power, and increases inequality in healthcare access.

Pharmacy Technician

PharmExec

AUGUST 1, 2025

drug prices to be as low as or lower than global prices, targeting 17 major pharmaceutical companies. drug prices to be as low as or lower than global prices, targeting 17 major pharmaceutical companies. That commitment has made the U.S.

Communication

Pharmaceutical Commerce

JUNE 13, 2025

The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by certain OECD countries—an approach previously blocked by courts. Concerns over price controls. What is MFN model pricing?

Drug Pricing

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. How will RFK Jr’s American dream for vaccines play out? From ADCs to TPDs, targeted therapies are transforming the treatment landscape for complex diseases. You will receive an email shortly. You will receive an email shortly.

Packaging

Pharmaceutical Commerce

JUNE 18, 2025

Being that TekniPlex Healthcare is indirectly involved with self-injectable devices, their prominence has brought various challenges for pharmaceutical companies to overcome, including the evolution of meds. The industry is evolving, and the success of drugs in new formats is paving the way for innovation across the board. “To

Drug Pricing

PharmExec

AUGUST 6, 2025

Companies like Merck are investing in domestic manufacturing and R&D to mitigate potential impacts and prepare for future scenarios. Stock.adobe.com It’s a bad time to try to predict future pharmaceutical prices. As the order would suggest, reducing drug prices is a high priority for the President.

Drug Pricing

Pharmaceutical Technology

AUGUST 5, 2025

Find out more This trade deal puts the pharmaceutical industry at risk of losing between $13bn and $19bn, with consequences that extend beyond short-term financials. This could hinder innovation and pipeline investment, reducing the much-needed pace of therapeutic innovation across the industry.

Immunity

PharmExec

AUGUST 8, 2025

The administration is considering raising international drug prices while lowering domestic prices to satisfy the MFN requirement. Challenges arise from government-negotiated drug prices in many countries, complicating efforts to raise international prices.

Drug Pricing

Pharmaceutical Technology

JUNE 30, 2025

Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.

Health and Personal Care Stores

Pharmaceutical Technology

JULY 2, 2025

The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceutical companies to invest in the country. How will RFK Jr’s American dream for vaccines play out?

Packaging

BioPharma Dive

JUNE 24, 2025

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. 4, 2024 Permission granted by Bristol Myers Squibb Deep Dive // Brain drug revival Psychiatry drugs finally have pharma’s attention.

Drug Pricing

Pharmaceutical Technology

JULY 16, 2025

Image credit: PeopleImages.com – Yuri A via Shutterstock With tighter budgets, regulatory challenges, and uncertainty from tariffs, pharmaceutical companies are turning to third-party logistics (3PL) suppliers to deliver efficiencies. How will RFK Jr’s American dream for vaccines play out?

Pharmaceutical Companies

BioPharma Dive

JUNE 11, 2025

SciePro via Getty Images Dive Brief: The Food and Drug Administration has approved a new oral medication for an uncommon kind of tumor, clearing Nuvation Bio’s Ibtrozi on Wednesday for certain people whose metastatic non-small cell lung cancer has a type of alteration in the gene ROS1. You can unsubscribe at anytime. or its subsidiaries.

Drug Pricing

Pharmaceutical Technology

JUNE 6, 2025

In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. We need to fundamentally change that so that we are focusing on curing disease and making people better.”

Insurance Coverage and Processing

Pharmaceutical Technology

AUGUST 4, 2025

Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country.

Communication

Pharmaceutical Technology

JUNE 27, 2025

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest does – is $1,350 in the US, whereas the same dose in the UK costs £175.80

Drug Pricing

Pharmaceutical Technology

JULY 31, 2025

Manasi Vaidya August 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook President Trump has sent letters to several leading pharmaceutical manufacturers outlining steps they need to take in line with the administration’s Most Favored Nation policy to bring down drug prices in the US.

Drug Pricing

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? If successful, this could fundamentally alter how drugs are designed, not by replacing AI, but by complementing it with physics-derived accuracy out of reach of classical computers.

Packaging

BioPharma Dive

JULY 31, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Vaccines Experts ousted from CDC panel warn of damage to US vaccine policy The 17 advisers fired last month by Robert F. You can unsubscribe at anytime. TechTarget, Inc.s

Vaccines

Pharmaceutical Technology

JUNE 10, 2025

Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands. He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceutical companies. Data Insights The gold standard of business intelligence.

Vaccines

PharmExec

AUGUST 1, 2025

Related Videos Related Content Advertisement August 1st 2025 President Trump Issues Letters to 17 Major Pharma Companies Demanding Action on Most-Favored-Nation Order Mike Hollan The letter states that the companies have 60 days to meet the President's requirements.

Communication

BioPharma Dive

JULY 10, 2025

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. 4, 2024 Adeline Kon / BioPharma Dive/BioPharma Dive Deep Dive // Patent thickets Drug patents protect pharma profits.

Drug Pricing

BioPharma Dive

JULY 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Merck to buy Verona and its lung drug in $10B deal The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Drug Pricing

STAT

JUNE 21, 2023

“They talk in such generalities on this subject that it’s difficult for me to tell where they’re coming from,” he said at a STAT event Wednesday, speaking about top GOP senators’ approach to reforming the drug pricing middlemen who negotiate between pharmaceutical companies and insurers.

Drug Pricing